Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). (Q55057343)

16 June 2018

title

Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). (English)

1 reference

16 June 2018

0 references

1 reference

4

1 reference

16 June 2018

Arjen Dondorp

6

object named as

Arjen M Dondorp

1 reference

16 June 2018

8

Tom van der Poll

1 reference

16 June 2018

Liesbeth M Kager

1

1 reference

16 June 2018

Tassili A Weehuizen

2

1 reference

16 June 2018

W Joost Wiersinga

3

1 reference

16 June 2018

Joost C M Meijers

5

1 reference

16 June 2018

Cornelis van 't Veer

7

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 October 2013

1 reference

16 June 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

16 June 2018

volume

188

1 reference

16 June 2018

issue

8

1 reference

16 June 2018

page(s)

967-975

1 reference

16 June 2018

Inflammation and coagulation

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Phylogenetic and functional relationships between coagulation and the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Antiplasmin: the forgotten serpin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Differences in coagulation and fibrinolysis after traumatic and septic shock in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Pleiotropic functions of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Melioidosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

alpha2-antiplasmin is associated with the progression of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Cellular and molecular basis for the regulation of inflammation by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Expression and function of transforming growth factor β in melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

Viral research faces clampdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201307-1344OC

10.1164/RCCM.201307-1344OC

21 January 2018

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

23992406

1 reference

16 June 2018